β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
about
Intravitreal injection of IGFBP-3 restores normal insulin signaling in diabetic rat retinaβ1-adrenergic receptor stimulation by agonist Compound 49b restores insulin receptor signal transduction in vivo.Etanercept restores normal insulin signal transduction in β2-adrenergic receptor knockout mice.Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor α and suppressor of cytokine signaling 3.TNFα inhibits IGFBP-3 through activation of p38α and casein kinase 2 in human retinal endothelial cellsAdrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability.Sodium salicylate reduced insulin resistance in the retina of a type 2 diabetic rat model.β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.Beta-adrenergic receptor agonist decreases VEGF levels through altered eNOS and PKC signaling in diabetic retina.Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice.The microRNA-7-mediated reduction in EPAC-1 contributes to vascular endothelial permeability and eNOS uncoupling in murine experimental retinopathy.Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy.TLR4 regulates insulin-resistant proteins to increase apoptosis in the mouse retina.
P2860
Q28541783-BA624BB4-188C-4E71-9212-69609D86A020Q33793115-FEB1C4FD-9A0B-4789-8A74-A2D945563BD9Q34109250-4409C772-C663-4E6C-93CC-6F66E9399CB1Q34249131-642D2530-C419-4CD2-87AF-15FC409A5C27Q35215117-017FF125-973B-42F7-8CC3-292E555DA33DQ35555144-559276B4-BF3C-4E80-BCCB-93B1DB368EBFQ35601488-9A4CD5A6-3525-41AE-B1C2-2BB0A71D1132Q36257726-F9202331-F55A-4C62-A56E-FF8A46A5BFA4Q36687280-B73676A0-68DA-4E55-811E-194A7C96700CQ37619293-91D9A2CA-2FAE-4CD9-8605-01B56A611064Q38869656-5760DD31-83E7-45D3-9F25-5A7FE0C7C77DQ39009395-C2471E43-21AF-49A8-A38F-7E8F2E2812D8Q48169940-394054CE-6B12-4E92-898F-21DB5340E061
P2860
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@ast
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@en
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@nl
type
label
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@ast
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@en
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@nl
prefLabel
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@ast
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@en
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@nl
P2093
P2860
P1433
P1476
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.
@en
P2093
Jena J Steinle
Qiuhua Zhang
Timothy S Kern
Youde Jiang
P2860
P304
P356
10.1371/JOURNAL.PONE.0070555
P407
P577
2013-07-24T00:00:00Z